Evaluating Pneumocystis Jiroveci Pneumonia Prophylaxis in Lung Transplant Recipients

被引：0
|
作者：
Sharkey, J. [1 ]
McMurry, K. [1 ]
Park, J. [1 ]
Carlson, C. [1 ]
Gregg, K. [1 ]
Kaul, D. [1 ]
Lyu, D. [1 ]
Fitzgerald, L. [1 ]
机构：
[1] Michigan Med, Ann Arbor, MI USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2021年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
230
引用
收藏
页码：409 / 409
页数：1
相关论文
共 50 条
  • [31] Late Incidence of Pneumocystis jiroveci Pneumonia in Renal Transplant Recipients and the Role of Trimethoprim-Sulfamethoxazole in Long Term Prophylaxis: A Single Center Experience
    Rajendran, P.
    Krishnan, P.
    Ramadas, P.
    Bhaskaran, M.
    Molmenti, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 629 - 629
  • [32] Late Incidence of Pneumocystis jiroveci Pneumonia in Renal Transplant Recipients and the Role of Trimethoprim-Sulfamethoxazole in Long Term Prophylaxis: A Single Center Experience
    Rajendran, P.
    Krishnan, P.
    Ramadas, P.
    Bhaskaran, M.
    Molmenti, E.
    TRANSPLANTATION, 2014, 98 : 629 - 629
  • [33] Pneumocystis pneumonia in liver transplant recipients
    Li, Xian-Liang
    Liu, Zi-Xi
    Liu, Zhen-Jia
    Li, Han
    Wilde, Benjamin
    Witzke, Oliver
    Qi, Man
    Xu, Wen-Li
    He, Qiang
    Zhu, Ji-Qiao
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (12): : 13981 - 13992
  • [34] Outbreak of pneumocystis jiroveci pneumonia among renal transplant patients
    Tachibana, Sayaka
    Inoue, Koji
    Siojiri, Masaaki
    Nakanishi, Norihiko
    Moritaka, Tomonori
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [35] RISK FACTORS FOR LATE OCCURING PNEUMOCYSTIS JIROVECI PNEUMONIA IN RENAL TRANSPLANT RECIPIENTS: A CASE CONTROL STUDY
    De Castro, Nathalie
    Abboud, Imad
    Pillebout, Evangeline
    Porcher, Raphael
    Glotz, Denis
    Molina, Jean-Michel
    Peraldi, Marie-Noelle
    TRANSPLANT INTERNATIONAL, 2009, 22 : 289 - 289
  • [36] Clindamycin–primaquine for pneumocystis jiroveci pneumonia in renal transplant patients
    P. Nickel
    M. Schürmann
    H. Albrecht
    R. Schindler
    K. Budde
    T. Westhoff
    J. Millward
    N. Suttorp
    P. Reinke
    D. Schürmann
    Infection, 2014, 42 : 981 - 989
  • [37] Recent Rise in the Incidence of Pneumocystis Jirovecii Pneumonia in Heart and Lung Transplant Recipients beyond the Standard Prophylaxis Interval
    Fulton, J. C.
    Hajari, A. S.
    Barney, J.
    Tallaj, J. A.
    Pamboukian, S.
    Gaggar, A.
    Leon, K.
    DeAndrade, J.
    Pajaro, O. E.
    McGiffin, D. C.
    Young, K. R.
    Wille, K. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [38] The Prevalence of Pneumocystis jiroveci in Bronchoalveolar Lavage Specimens of Lung Transplant Recipients Examined by the Nested PCR
    Izadi, Morteza
    Jafari, Nematollah Jonaidi
    Sadraei, Javid
    Poornaki, Abbas Mahmoodzadeh
    Rezavand, Babak
    Zarrinfar, Hossein
    Abdi, Jahangir
    Mohammadi, Younes
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2014, 7 (12)
  • [39] Safety of Dapsone for Pneumocystis Jiroveci Pneumonia Prophylaxis in Patients With Multiple Myeloma
    Kim, Mingee
    Arabi, Jessica
    McCoy, Cole
    D'Souza, Anita
    Chhabra, Saurabh
    Abid, Muhammad Bilal
    Thapa, Bicky
    Dhakal, Binod
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (11): : 804 - 807
  • [40] A Single-Center Experience with a 6-Month Regimen of Pneumocystis jiroveci Pneumonia Prophylaxis in HIV-Positive Kidney Transplant Recipients.
    Mejia, C.
    Malat, G.
    Lee, D. H.
    Epstein, S.
    Harhay, M.
    Mizrahi, L. Levin
    Ranganna, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 390 - 391
12345